Study of VB10.NEO in Combination With Atezolizumab in Solid Tumors
Clinical trial NCT05018273 · COMPLETED
Trial details
- NCT number
- NCT05018273
- Sponsor
- Nykode Therapeutics ASA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-21
- Primary completion
- 2024-10-09
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.